Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC

Overview of attention for article published in Biomarker Research, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

reddit: 1 Redditor

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer

Article in International Journal of Molecular Sciences (February 2024)

Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry

Article in Frontiers in Immunology (August 2023)

Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors

Article in Frontiers in Oncology (September 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.